The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infectionArticle Published on 2021-09-012023-06-12 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] hepatitis B surface antigen Hepatitis B virus immune response Natural killer cells [DOI] 10.1111/liv.14885
Vitamin D deficiency correlates with a reduced number of natural killer cells in intensive care unit (ICU) and non-ICU patients with COVID-19 pneumoniaArticle Published on 2021-09-012023-07-12 Journal: Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē [Category] SARS, [키워드] COVID-19 Natural killer cells Vitamin D [DOI] 10.1016/j.hjc.2020.11.011 PMC 바로가기
Natural Killer Cells as Key Mediators in Type I Diabetes ImmunopathologyReview Published on 2021-08-202023-06-14 Journal: Frontiers in Immunology [Category] MERS, [키워드] Autoimmune beta cell immunopathology Natural killer cells Type 1 diabetes [DOI] 10.3389/fimmu.2021.722979 PMC 바로가기 [Article Type] Review
Innate Immune Response to Viral Infections at the Maternal-Fetal Interface in Human PregnancyReview Published on 2021-07-222023-08-30 Journal: Frontiers in Medicine [Category] E형 간염, [키워드] cytokine environment Innate immunity macrophages maternal-fetal transmission Natural killer cells Pregnancy viral infection [DOI] 10.3389/fmed.2021.674645 PMC 바로가기 [Article Type] Review
The role of NK cells in fighting the virus infection and sepsis바이러스 감염 및 패혈증과 싸우는 NK 세포의 역할Review Published on 2021-07-222022-09-10 Journal: International Journal of Medical Sciences [Category] MERS, SARS, 유전자 메커니즘, [키워드] alleviation Anti-viral Antiviral cells combating COVID-19 global pandemic Host immune response host immune responses immune cells immune responses Immunotherapy in viral in vivo Infection Innate immune cells mechanism natural Natural killer cells NK cell NK cells Novel coronavirus pandemic progression promote SARS-CoV-2 Sepsis Severe infection shown treating COVID-19 Viral viral infection viral infections virus infection [DOI] 10.7150/ijms.59898 PMC 바로가기 [Article Type] Review
Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19Review Article Published on 2021-07-212024-09-04 Journal: Heliyon [Category] 대상포진, [키워드] COVID-19 Cytokines Natural killer cells pulmonary inflammation SARS-CoV-2 [DOI] 10.1016/j.heliyon.2021.e07635 PMC 바로가기 [Article Type] Review Article
Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities비만 및 중증 코로나 바이러스 질병 2019 : 분자 메커니즘, 경로 및 치료 기회Review Published on 2021-07-132022-09-10 Journal: Theranostics [Category] MERS, 유전자 메커니즘, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus adverse events antiviral immunity antiviral responses appear assist B cell body mass body mass index caused chronic Clinicians Comorbidity Complication contribute coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic cytokine Cytokine storm damage deficiency demonstrated dendritic cell disease severity disorder dyslipidemia early stage Endothelial dysfunction exacerbate greater Host-directed therapies host-directed therapy hypercoagulability hyperglycemia Immunity impair increase Inflammation interferon leads mechanism Metabolic disorders metabolism molecular mechanisms natural killer Natural killer cells obesity open organ dysfunction pandemic pathogenicity patients with obesity platelet hyperactivation polymorphism Polymorphisms poor prognosis progression prothrombotic state researcher respiratory resulting risk SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe coronavirus disease severe COVID-19 severe symptom severe symptoms susceptibility systemically T cell T cells therapeutic thrombosis tissue damage underlying diseases Ventilation vicious cycle Viral Viral load viral mutation Vitamin D vitamin D deficiency worsening [DOI] 10.7150/thno.59293 PMC 바로가기 [Article Type] Review
Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions병원성 유비퀴틴화된 GSDMB는 NK 세포의 세균 살해 기능을 억제한다.Article Published on 2021-06-102024-08-22 Journal: Vet Hist [Category] 세균성이질, [키워드] E3 ubiquitin ligase gasdermin GSDMB GzmA Inflammasome ipaH lytic cell death mucosal immunity Natural killer cells
Is malaria immunity a possible protection against severe symptoms and outcomes of COVID-19?말라리아 면역은 코로나19의 심각한 증상과 결과에 대한 보호가 가능한가요?Special Article Published on 2021-06-012022-10-31 Journal: Ghana Medical Journal [Category] COVID-19, MERS, SARS, 말라리아, [키워드] Activation asymptomatic infections benefit component contribute COVID-19 disease Effect endemic area evaluate funding help highlight Immunity Infection Innate immunity interferon majority malaria Malaria immunity mitigate morbidity and mortality Natural killer cells other diseases outbreak Outbreaks outcome parasites Plasmodium Prevent PROTECT Research resulting severe symptom Tolerance [DOI] 10.4314/gmj.v55i2s.9 PMC 바로가기 [Article Type] Special Article
JAK-STAT Pathway Inhibition and their Implications in COVID-19 TherapyJAK-STAT 경로 억제 및 COVID-19 치료에 미치는 영향Review Published on 2021-06-012022-09-11 Journal: Postgraduate medicine [Category] 유전자 메커니즘, 치료법, [키워드] 3CL pro activated Activation adverse effects B cell Baricitinib clinical trial contrary COVID-19 COVID-19 patients COVID-19 therapy cytokine cytokine receptor cytokine signaling Cytokine storm dendritic cell dendritic cells determine Disease progression disease severity Efficacy effort endothelial cells envelope protein envelope proteins excessive inflammation Host hosts immune response immune responses implicated incidence of COVID-19 increase Inflammation Inflammatory marker inflammatory markers Inflammatory mediators inhibition inhibitor inhibitors Jak Jak-STAT JAK/STAT JAK/STAT pathway JAK/STAT signaling janus Janus kinase Lymphocytes macrophages mechanism membrane molecular Monocytes natural killer cell Natural killer cells nucleocapsid nucleus Phosphorylation Pneumocytes progression promote protease Proteases Protein recruitment reduce Regulatory Authorities regulatory authority required ruxolitinib SARS-CoV-2 SARS-COV-2 infection severity signaling cascade signaling cascades STAT STATs structural protein structural proteins supported suppressor suppressors survival T cell the disease Therapeutic strategies therapeutic strategy Tofacitinib translate Trigger tyrosine [DOI] 10.1080/00325481.2020.1855921 PMC 바로가기 [Article Type] Review